Table 5.
Variables | Prevalence∗∗ (%) | Metabolic syndrome | Prevalence∗∗ (%) | Hypertension | Prevalence∗∗ (%) | CVD |
---|---|---|---|---|---|---|
Adjusted model OR (95% CI) |
Adjusted model OR (95% CI) |
Adjusted model OR (95% CI) |
||||
ALT | ||||||
Quartile 1 | 17.7 | 1.00 | 23.2 | 1.00 | 23.9 | 1.00 |
Quartile 2 | 22.1 | 1.17 (0.96–1.42) | 26.9 | 0.92 (0.72–1.16) | 27 | 0.95 (0.75–1.20) |
Quartile 3 | 27 | 1.68 (1.38–2.03) | 27.5 | 0.90 (0.70–1.15) | 26.8 | 1.02 (0.80–1.29) |
Quartile 4 | 17.2 | 2.38 (1.90–2.98) | 12.4 | 0.93 (0.69–1.26) | 12.9 | 1.21 (0.90–1.61) |
| ||||||
AST | ||||||
Quartile 1 | 24.7 | 1.00 | 24.7 | 1.00 | 26.2 | 1.00 |
Quartile 2 | 23.6 | 0.95 (0.79–1.13) | 24.9 | 0.94 (0.74–1.28) | 25.4 | 0.97 (0.77–1.21) |
Quartile 3 | 24.9 | 1.08 (0.91–1.30) | 26.7 | 1.02 (0.81–1.29) | 25.3 | 0.96 (0.76–1.21) |
Quartile 4 | 19.8 | 1.13 (0.93–1.38) | 18.7 | 1.02 (0.79–1.33) | 17.9 | 1.01 (0.72–1.50) |
ALT: alanine aminotransferase; AST: aspartate aminotransferase. ∗Adjusted model for gender, age, smoking status, physical activity, and BMI. ∗∗Without adjusted models.